Kyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America
(RTTNews) - Tuesday, Kyowa Kirin (4151.T) said it entered into an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in select Latin American countries.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.